NR3C1 and neoplasm: Although our studies would predict that only tumors uniformly expressing relatively high levels of GR would respond optimally to the anti-proliferative effect of long-term treatment with Dex, the senescence phenotype induced by Dex in tumors that are heterogeneous in GR expression should also elicit an anti-tumor immune response following Dex withdrawal.